S. R. Schill & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History
S. R. Schill & Associates
- $125 Million
- Q1 2025
A detailed history of S. R. Schill & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, S. R. Schill & Associates holds 41,595 shares of XBI stock, worth $3.29 Million. This represents 2.7% of its overall portfolio holdings.
Number of Shares
41,595Holding current value
$3.29 Million% of portfolio
2.7%Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
847Shares Held
109MCall Options Held
17.7MPut Options Held
28.5M-
Goldman Sachs Group Inc New York, NY13.1MShares$1.04 Billion0.18% of portfolio
-
Morgan Stanley New York, NY10.9MShares$864 Million0.07% of portfolio
-
Citigroup Inc10.5MShares$830 Million0.45% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$821 Million0.07% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A68.49MShares$672 Million1.54% of portfolio